{"disease":{"id":"reversal-of-neuromuscular-blockade","name":"Reversal of neuromuscular blockade","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"neostigmine","indication_name":"Reversal of neuromuscular blockade","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bloxiverz","generic_name":"NEOSTIGMINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Bloxiverz works by blocking the enzyme acetylcholinesterase, allowing more acetylcholine to be available in the nervous system."},{"drug_id":"edrophonium","indication_name":"Reversal of neuromuscular blockade","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tensilon","generic_name":"EDROPHONIUM","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":36,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06246331","title":"Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT03346057","title":"Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07044180","title":"Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Tamas Vegh, MD","has_results":false},{"nct_id":"NCT07044193","title":"Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Tamas Vegh, MD","has_results":false},{"nct_id":"NCT06436768","title":"Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}